Review
Aug 2026
[Evolving Role of Perioperative Immune Checkpoint Inhibitors in Muscle-Invasive Bladder Cancer].
Current developments in perioperative ICI-based therapies for muscle-invasive bladder cancer indicate a shift toward more personalized and biomarker-driven treatment approaches in MIBC.
Takashi Kawahara, Hiroyuki Nishiyama
· Gan to kagaku ryoho. Cancer... · 0 citations